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Cockayne syndrome (CS) is an accelerated aging dis-
order characterized by progressive neurodegenera-
tion caused by mutations in genes encoding the
DNA repair proteins CS group A or B (CSA or CSB).
Since dietary interventions can alter neurodegenera-
tive processes, Csbm/m mice were given a high-fat,
caloric-restricted, or resveratrol-supplemented diet.
High-fat feeding rescued the metabolic, transcrip-
tomic, and behavioral phenotypes of Csbm/m mice.
Furthermore, premature aging in CS mice, nema-
todes, and human cells results from aberrant PARP
activation due to deficient DNA repair leading to
decreasedSIRT1 activity andmitochondrial dysfunc-
tion. Notably,b-hydroxybutyrate levels are increased
by the high-fat diet, and b-hydroxybutyrate, PARP
inhibition, or NAD+ supplementation can activate
SIRT1 and rescueCS-associated phenotypes.Mech-
anistically, CSB can displace activated PARP1 from
damaged DNA to limit its activity. This study con-
nects two emerging longevitymetabolites, b-hydrox-
ybutyrate and NAD+, through the deacetylase SIRT1
and suggests possible interventions for CS.
INTRODUCTION
Cockayne syndrome (CS) is a progressive neurodegenerative
accelerated aging disorder caused by mutations in the CSA or
CSB genes, which encode proteins that are involved in DNA
repair and transcriptional regulation. Interestingly, Csbm/m mice
and CSB-deficient cells have mitochondrial alterations, and CS840 Cell Metabolism 20, 840–855, November 4, 2014 ª2014 Elsevierpatients share the same neurodegenerative traits that are seen
in many mitochondrial disorders (Scheibye-Knudsen et al.,
2013b). Mice are often used for longevity studies; however,
models of age-related neuropathologies such as Alzheimer’s
disease and Parkinson’s disease may not reflect normal human
brain aging (Jucker, 2010). Csbm/mmice displaymany features of
mild human CS such as smaller brain weight, inner ear pathol-
ogy, neuroinflammation, and weight loss (Scheibye-Knudsen
et al., 2012). The Csbm/m mouse may therefore be a good model
for the study of neuronal aging, and interventions that attenuate
the CS phenotype may also counteract brain aging in humans.
Poly-ADP-ribose polymerase 1 (PARP1) catalyzes the conver-
sion of NAD+ molecules to poly-ADP-ribose (PAR) and nicotin-
amide upon binding to DNA damage. PAR is conjugated to
histones and other proteins in the vicinity of the DNA lesion
and is believed to participate in the modulation of the DNA repair
response. Recent progress has shown that PARP1 activation in-
creases with age, perhaps reflecting an age-related increase in
DNA damage (Mouchiroud et al., 2013). Although PARP1 is a
critical DNA repair enzyme, persistent activation may be harmful
for the organism. Indeed, pharmacological inhibition of PARP or
supplementation with NAD+ precursors can extend the lifespan
of worms, return tissue functionality to a more youthful state in
mice, and rescue mitochondrial dysfunction in some DNA repair
disorders (Gomes et al., 2013; Fang et al., 2014; Mouchiroud
et al., 2013). Interestingly, the NAD+-dependent deacetylase
SIRT1 is required for these effects (Gomes et al., 2013; Mouchir-
oud et al., 2013).
Since different diets can modulate neurodegenerative phe-
notypes, we investigated the effect of a high-fat diet (HFD),
caloric restriction (CR), and resveratrol supplementation on the
phenotype of wild-type (WT) and Csbm/m mice. Remarkably,
the HFD rescued the metabolic and cerebellar phenotype of
the Csbm/mmice. SIRT1 was attenuated in Csbm/m mice, worms,
and patient cells due to PARP1 activation and NAD+ depletion.Inc.
Figure 1. A HFD Rescues the Metabolic Phenotype of Csbm/m Mice
(A) Body weights of WT and Csbm/m mice on various diets; SD: Standard diet; HFD: High fat diet; Resv: resveratrol-supplemented standard diet; CR: Caloric
restricted (n = 12–14, mean ± SEM).
(B) Feeding efficiency shown by weight gain per food intake (n = 12–14, mean ± SEM).
(C) Whole-body oxygen consumption over 72 hr (n = 12–14, mean ± SEM).
(D) Respiratory exchange rates (n = 12–14, mean ± SEM).
(E) Heat production (n = 12–14, mean ± SEM).
(F) OGTTs performed after 3 hr fasting (n = 5–9, mean ± SEM).
(G) Insulin levels after 3 hr fasting (n = 7–11, mean ± SEM).
(H) Glucose levels after 3 hr fast (n = 5–9, mean ± SEM).
(I) Representative images of liver histology stained with hematoxylin and eosin.
(legend continued on next page)
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A High-Fat Diet for Cockaynes Syndromeb-hydroxybutyrate (b-OHB) levels were increased in the HFD-
treated mice, and this ketone body increased SIRT1 expression
and activity in CSB-deficient cells. Interestingly, PARP1 inhibi-
tion and b-OHB rescued the shortened lifespan of CSB-deficient
nematodes. PARP inhibition or supplementation with an NAD+
precursor rescued metabolic, mitochondrial, and transcriptional
alterations in Csbm/m mice. At the molecular level, CSB is able to
displace activated PARP1 from damaged DNA, thereby shutting
downs its PARylating activity and restoring NAD+ levels. Consid-
ering that CS is an accelerated aging disorder with features
similar to late-stage human aging, a ketogenic diet might prove
neuroprotective in older individuals, as previously suggested
(Maalouf et al., 2009). In addition, since no treatment is currently
available for CS patients, NAD+ augmentation or a ketogenic diet
could be adapted for this devastating disease.
RESULTS
A HFD Normalizes the Metabolism of Csbm/m Mice
To test the hypothesis that dietary intervention may ameliorate
the metabolic defects exhibited by CS mammalian models, 4-
month-old male WT and Csbm/m mice were randomized to
8 months of a standard diet (SD), a HFD (61% kcal from fat
and 16% from carbohydrates), a 40% CR SD, and a SD supple-
mented with 100 mg/kg resveratrol. During the treatment, we
monitored bodyweight, food intake, and body temperature to
define the consequences of the various dietary interventions
(Figure 1A; Figures 1A–S1G available online). Interestingly,
Csbm/m mice gained significantly less body weight than WT
mice on all diets, with the exception of mice fed resveratrol.
Indeed, Csbm/m mice on a HFD ended up weighing the same
as WT mice on a SD. Feeding efficiency, which measures the
weight gain per gram food consumed, decreased over time
particularly in the Csbm/m mice, indicating an age-associated in-
crease in metabolism (Figure 1B). We therefore investigated the
metabolism by housing the mice in metabolic cages and
observed increased oxygen consumption rates in Csbm/m mice
compared with WT animals under SD (Figures 1C–1E, S1H,
and S1I). The increased metabolism in Csbm/m mice was attenu-
ated by a HFD, while the CR Csbm/m mice displayed greatly
increased oxygen consumption rates (Figure 1C). Notably, the
respiratory exchange ratio (RER) (O2 consumption / CO2 produc-
tion) revealed that Csbm/mmice on aHFD switched completely to
b-oxidation, as evident by an RER of 0.7 (Figure 1D). Heat pro-
duction was severely decreased in CR mice compared with SD,
particularly for the Csbm/m genotype, while the HFD increased
the heat production in Csbm/m mice (Figure 1E). In summary,
the HFD appeared to normalize the metabolism of Csbm/m
mice, while CR exacerbated this phenotype.
No Adverse Effects of a HFD in Csbm/m Mice
A common effect of prolonged ingestion of a HFD is steatohepa-
titis and diabetes. To investigate these outcomes, we performed
oral glucose tolerance tests (OGTTs), measured circulating(J) Representative images of scanning electron microscopy of the sinusoidal end
(K) Quantification of the fenestration diameter of the liver sinusoid (n = 4,000–6,0
(L) The porosity of the liver using the diameter measured in (K) and the total sur
information.
842 Cell Metabolism 20, 840–855, November 4, 2014 ª2014 Elsevierlevels of insulin, and investigated liver histopathology. Interest-
ingly, the HFD Csbm/m mice displayed decreased glucose levels
in the OGTT and very low insulin levels as compared toWTmice,
indicating well-regulated glucose homeostasis (Figures 1F–1H).
Notably, the Csbm/m mice on CR were found to be severely
hypoglycemic after only 3 hr fasting and had profound insulin
sensitivity, as revealed by the OGTT and low insulin levels (Fig-
ures 1F–1H). Histology revealed minimal lipid accumulation in
the livers of HFD- and SD-fed Csbm/m mice, in contrast to the
SD- and HFD-fedWTmice, who exhibited marked lipid accumu-
lation (Figure 1I).
An effect of the HFD is basal membrane and endothelial thick-
ening and a loss of fenestrations in the liver sinusoid linked
to decreased liver endothelial function (Fraser et al., 2012).
We therefore performed transmission and scanning electron mi-
croscopy (TEM and SEM, respectively). Consistent with the
histological results, sinusoidal endothelium appeared thinner in
TEM micrographs with less basal membrane thickening in the
Csbm/m mice compared with WT mice (Figure S1J, endothelium
is labeled e). SEM of SD- and HFD-fed WT mice showed
decreased fenestrations, consistent with the fatty liver observed
with light microscopy (Figure 1J; a fenestration is indicated by
the triangle; sieve plate indicated by the highlighted area; quan-
tification in Figures 1K and 1L). Conversely, SD and HFD Csbm/m
mice had preserved endothelium porosity and sieve plate forma-
tion, indicating a healthier endothelium relative to the WT mice.
Taken together, these data indicate that a HFD rescued the
metabolic phenotype of Csbm/m mice without any adverse ef-
fects, while CR led to hypoglycemia and an exacerbation of
the phenotype in these animals.
A HFD Normalized the Cerebellar and Auditory
Neurological Phenotypes of Csbm/m Mice
The cerebellum is severely affected in CS, and thus, we investi-
gated the effect of the diets on this brain region in detail. We
started by performing gene expression array to investigate over-
all changes in the transcriptome. Principal component analysis
(PCA) revealed separation of genotypes along principal compo-
nent 1 (PC1) (x axis, Figure 2A). PC2 (y axis) appeared to
describe alterations caused by the diets, since there was no dif-
ference in this component between SD-treated WT and Csbm/m
mice. Surprisingly, the HFD and resveratrol treatment led to an
almost identical transcriptome in both WT and Csbm/m mice,
indicating a common target for these interventions (Figures 2A
and S2A). When considering the genotype-dependent variability
(x axis, PC1), it appeared that the HFD and resveratrol treatment
of Csbm/m mice led to a normalization of the genotype effect on
the transcriptome. Indeed, the HFD- and resveratrol-treated
Csbm/m mice were relatively similar to the CR WT group when
performing hierarchical clustering (Figure 2A).
Since the brain does not metabolize fatty acids and aHFDmay
generate ketone bodies, we speculated that these metabolites
may play a role in the transcriptional effects observed. Indeed,
circulating levels of b-OHB were moderately increased in theothelium (triangle: fenestration example; highlighted area: sieve plate).
00 from three mice in each group, mean ± SD).
face area of the endothelium (n = 3, mean ± SEM). See Figure S1 for further
Inc.
(legend on next page)
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A High-Fat Diet for Cockaynes SyndromeHFD-treated mice (Figure 2B). To further understand if these
levels of circulating ketones could alter tissue levels of ketone
bodies, we proceeded to investigate this in the brain. At the tis-
sue level, b-OHB was significantly decreased in the brain of SD.
Csbm/m mice compared with the WT, and the HFD completely
rescued this defect (Figure 2C). To further investigate changes
in metabolites, we performed untargeted metabolomics analysis
on the cerebellum from the mice. Orthogonal partial least-
squares regression showed similar effects of a HFD and CR on
the entire metabolome of both WT and Csbm/m mice (Figure 2D).
However, none of the dietary interventions were able to shift the
metabolome of the Csbm/m mice toward WT, indicating that the
metabolic alterations in Csbm/m could not be corrected by die-
tary interventions. Surprisingly, resveratrol had negligible effects
on the cerebellar metabolome, perhaps indicating that resvera-
trol acts by altering the activity of central transcription factors,
such as SIRT1, and that the fuel source has a much stronger
effect on overall metabolomics compared to transcriptional
alterations.
Ketogenic amino acids appeared to be decreased when
comparing Csbm/m mice to WT, perhaps indicating an increased
ketolysis from amino acids (Figure 2D). Ketones are metabolized
in the brain to form acetyl-CoA, a precursor for citrate andmyelin
synthesis. In agreement with an increase in ketolysis, citrate
levels were decreased in the cerebellum (Figure 2D). Ketones,
decreases brain inflammation (Jeong et al., 2011) and succinate,
an inflammatory marker in the brain (Tannahill et al., 2013), was
significantly increased in the cerebellum of Csbm/m mice (Fig-
ure 2D). To further investigate the effect of the diets on the cere-
bellum, we performed TEM on tissue from Csbm/m mice and
observed an increased postsynaptic density length after the
HFD treatment (Figures S3B and S3C). We assessed cerebellar
function utilizing the rotarod and found a better performance of
Csbm/mmice compared toWT, whichmay reflect the large differ-
ences in body weight (Figure S2D). In summary, the HFD ap-
pears to normalize cerebellar alterations in Csbm/m mice.
Hearing loss is a hallmark feature of CS, aging, and mitochon-
drial diseases, and we have recently reported an age-associated
loss of spiral ganglion cells in Csbm/m mice (Scheibye-Knudsen
et al., 2012). To determine the extent of the hearing loss, we per-
formed hearing tests on the mice and assessed the histology of
the inner ear. Notably, the HFD protected the Csbm/m mice from
age-associated hearing loss at both the behavioral (Figure 2E)
and histological levels (Figures 2F and 2G, the spiral ganglion
is highlighted in blue in the micrographs). Conversely, the CRFigure 2. A HFD Increases b-OHB Levels and Rescues the Neurologic
(A) A PCA of the unselected average gene expression Z score from the cerebellu
(B) Levels of circulating b-OHB in the mice (n = 6–12, mean ± SEM).
(C) Levels of b-OHB in the brain of mice (n = 4–9, mean ± SEM).
(D) Orthogonal partial least square regression of metabolomics data done on the
genotype only. (n = 3–7).
(E) Hearing tests done by exposing the mice to a 108 db recorded clap, videotapi
sound (n = 10–14).
(F) Representative histological images of hematoxylin-and-eosin-stained section
(G) Quantification of cells in the spiral ganglion (n = 3, mean ± SEM).
(H) Aerobic capacity of the mice measured by forced treadmill exercise (n = 7–1
(I) Serum lactate levels (n = 7–12, mean ± SEM).
(J) ECARs of immortalized CSB patient cells (CS1AN) reconstituted with WT CSB
(K) NAD+/NADH ratio (n = 3, mean ± SEM).
844 Cell Metabolism 20, 840–855, November 4, 2014 ª2014 ElsevierCsbm/mmice were deaf and showed extensive loss of spiral gan-
glion cells. Since the reaction to sound may depend on anxiety
levels, we performed open field tests. Csbm/m mice were found
to be significantly less anxious than WT mice, a trait anecdotally
observed in CS patients. However, there was no difference be-
tween CR and HFD groups within the different genotypes, indi-
cating that the loss of an auditory behavioral response was
bona fide hearing loss (Figures S3A–S3C).
CSB Deficiency Leads to Lactate Production through a
Shift in the NAD/NADH Equilibrium
Sensorineural hearing loss is a common feature in mitochondrial
diseases, and mitochondrial dysfunction leads to exercise intol-
erance and muscle weakness. We therefore investigated the
aerobic capacity and muscle strength of Csbm/m mice. Surpris-
ingly, all the Csbm/m mice, except those on CR, ran longer on
the treadmill and were stronger than the WT counterparts (Fig-
ures 2H, S3D, and S3E). This finding was corroborated when
investigating the oxygen consumption rates of isolated mito-
chondria from the brain and liver of the different animals. Tighter
coupled mitochondria were observed in the brain of Csbm/m
mice, as indicated by decreased state-4 respiration (no ADP)
and an increased coupling ratio after ADP addition, while there
were no genotype differences in mitochondria isolated from
the liver (Figures S3F–S3K).
Lactate accumulation is a key feature of mitochondrial dis-
eases and is observed in the brain of CS patients (Koob et al.,
2010). Due to the increased cerebellar lactate observed in the
metabolomics analysis, we measured lactate levels in the serum
and found increased levels in Csbm/m mice (Figure 2I). This
observation was corroborated in cultured immortalized CSB pa-
tient fibroblasts were reconstitution with WT CSB (labeled WT
cells) decreased extracellular acidification rates (ECARs) as
compared with the empty vector (labeled CSB) reconstituted
cells (Figure 2J). Increased lactate production was particularly
surprising in light of our finding of increased aerobic perfor-
mance in the Csbm/m mice and could possibly be explained by
a shift in the lactate-pyruvate equilibrium toward lactate. This
seemed to be the case at the cellular level when investigating
the ability of lactate to stimulate oxygen consumption rates after
glycolysis had been inhibited with 2-deoxyglucose. In particular,
addition of lactate to WT cells lead to a significant increase
in oxygen consumption rates, while a much larger dose of
lactate was needed for the same stimulation in CSB cells (Fig-
ure S4A). The lactate-pyruvate equilibrium is regulated throughal Phenotype of Csbm/m Mice
m and a hierarchical clustering of the same data (n = 3–7).
same samples as in (D) and a list of some altered metabolites when comparing
ng the reaction, and subsequently blindly scoring the mice for a reaction to the
s of the inner ear (blue highlight: spiral ganglion).
1, mean ± SEM).
(WT) or an empty vector (CSB) (n = 28 separate experiments, mean ± SEM).
Inc.
Figure 3. PARP1 Activation Drives SIRT1 Depression and the Mitochondrial Phenotype in CSB-Deficient Cells
(A) Representative confocal microscopy images and quantification of WT and CSB-deficient cells stained for PARP1 and PAR (n = 3, mean ± SEM).
(B) Representative immunoblot of PAR, PARP1, PARG1, and UCP2 in WT and CSB-deficient cells (n = 3, mean ± SEM).
(legend continued on next page)
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A High-Fat Diet for Cockaynes Syndromephosphorylation of the pyruvate dehydrogenase by the pyruvate
dehydrogenase kinase (PDK) enzymes. However, we did not find
any difference in the expression of PDK1–PDK4 (Figure S4B).
Lactate dehydrogenase uses NADH as a reducing agent, con-
verting it to NAD+ (Figure S4C). One reason that CSB deficiency
increased lactate production could therefore be alterations in the
NAD+/NADH ratio. Indeed, the NAD+/NADH ratio was decreased
in CSB-deficient cells possibly explaining the shift in the lactate-
pyruvate equilibrium (Figure 2K). Collectively, our findings sug-
gest that the increased lactate production in CS may result
from alterations in the NAD+/NADH ratio.
PARP Activation Drives SIRT1 Activation in
CSB-Deficient Cells and Mice
DNA damage activates PARP1, leading to the formation of PAR
polymers and consumption of NAD+. Since we recently found
PARP activation in neurodegenerative DNA repair disorders
(Fang et al., 2014), we hypothesized that the defect in repairing
DNA damage in CS would lead to NAD+ depletion, explaining
the observed shift in the lactate-pyruvate equilibrium. Indeed,
PAR levels and the number of PARP1 foci were higher in
CSB-deficient cells than in WT cells (Figures 3A and 3B).
Concomitantly, the PAR-degrading enzyme PAR-glycohydro-
lase (PARG) was increased, possibly indicating greater PAR
turnover in CSB-deficient cells (Figure 3B). To further investigate
the role of PARP, we performed mass spectrometry on CSB-
deficient cells and measured NAD levels as well as metabolites
involved in PAR breakdown with and without inhibition of
PARP enzymes using PJ34 (Figure 3C). Although we did not
find any differences in total NAD levels (the combined concentra-
tion of NAD + and NADH) betweenWT andCSB cells, pharmaco-
logical inhibition of PARP for 24 hr led to a 2-fold increase in total
NAD levels, suggesting much larger recycling of PAR in CSB-
deficient cells than in WT (Figure 3C). In addition, the NAD+ pre-
cursor NMN was significantly decreased in CSB-deficient cells
(Figure 3C). Nicotinamide, a competitive inhibitor of SIRT1,
was increased in CSB-deficient cells. Quite strikingly, PARP
inhibition led to a 60%–80% reduction in nicotinamide levels,
indicating that this enzyme is responsible for the majority of
cellular nicotinamide production (Figure 3C).
Sirtuins are a family of NAD+-dependent deacetylases
believed to be involved in the aging process (Houtkooper et al.,
2012). We therefore investigated the protein levels of the sirtuins
and found that all of them, except SIRT6, were decreased in
CSB-deficient cells, corresponding with the increased PARP1
activation (Figure 3D). SIRT1 is particularly interesting since
it is known to regulate inflammation, apoptosis, and mitochon-
drial function, parameters that are altered in CS patients and
Csbm/m mice. In the cerebellum, PAR levels were increased in(C) Mass spectrometry of nicotinamide adenine dinucleotide (NAD) and NAD-me
NAM: Nicotinamide; (n = 6–8, mean ± SEM).
(D) Representative immunoblot of sirtuin levels in WT and CSB-deficient cells.
(E) Immunoblot of protein levels from the cerebellum of WT and Csbm/m mice on
(F) FCCP uncoupled respiration normalized to basal respiration under various 24
(G) FCCP uncoupled respiration normalized to basal respiration 72 hr after SIRT1
(H) FCCP uncoupled respiration normalized to basal respiration 72 hr after UCP2
(I) Flow cytometry of WT and CSB-deficient cells after overexpression of UCP2
potential and mitosox for mitochondrial superoxide production (n = 3, mean ± S
846 Cell Metabolism 20, 840–855, November 4, 2014 ª2014 ElsevierSD Csbm/m mice, correlating with the decreased SIRT1 levels.
SIRT1 activity was also attenuated, as revealed by the hyperace-
tylation of p53 and p65 (an NFkB subunit) substrates compared
with SD WT mice (Figure 3E). Increased p65 acetylation has
been reported to lead to microglial activation and may explain
the proinflammatory state in CS (Weidenheim et al., 2009).
Furthermore, hyperacetylated p53 could contribute to the
increased apoptosis seen in CS. Indeed, proapoptotic BAX
was increased while antiapoptotic Bcl-2 and Bcl-xL were
decreased in the cerebellum of Csbm/m mice compared with
WT animals (Figure 3E). These changes were ameliorated to
some extent by the HFD, resveratrol, and CR, indicating com-
mon targets in these interventions, perhaps mediated through
ketone body metabolism. Taken together, these data suggest
that PARP activation leads to SIRT1 attenuation contributing to
the proinflammatory and proapoptotic state seen in CS.
PARP-Mediated Attenuation of SIRT1 Leads to
Mitochondrial Dysfunction in CS
To test whether PARP1 and SIRT1 could be responsible for the
mitochondrial alterations seen in CS, we took advantage of the
increase in carbonyl cyanide 4-(trifluoromethoxy) phenylhydra-
zone (FCCP)-uncoupled respiration seen in CSB-deficient cells
compared with WT (Scheibye-Knudsen et al., 2012). The SIRT1
activators, resveratrol and SRT1720, attenuated the increased
FCCP-uncoupled respiration in CSB-deficient cells (Figure 3F).
The same outcome was achieved with the PARP inhibitors,
3-aminobenzamide (3AB), PJ34, and NU1025 (Figure 3F).
Knockdown of SIRT1 rendered both WT and CSB-deficient cells
insensitive to PARP inhibition, indicating that SIRT1 acts down-
stream of PARP activation (Figure 3G). Oxidative DNA lesions
can lead to PARP1 activation, and we therefore investigated
the effect of culturing the cells in low oxygen. Indeed, incubation
in 3% oxygen led to a decrease in FCCP-uncoupled respiration
in both WT and CSB-deficient cells (Figure S5A). This effect did
not appear to be caused by HIF-1a or HIF-2a activation, since
inhibition with LW6 or knockdown of these transcription fac-
tors also decreased FCCP-uncoupled respiration (Figure S5A).
In addition, the effects of resveratrol were likely not through
AMPK, as treatments with the AMPK agonists AICAR and
AG769662 or the antagonist dorsomorphin did not lead to
any consistent changes (Figure S5A). The relative increase in
FCCP-uncoupled respiration could be caused by increased
membrane potential. Uncoupling proteins (UCPs) regulate
membrane potential, and we recently found that UCP2 was
decreased in DNA-repair-deficient diseases (Fang et al., 2014).
Indeed, UCP2 levels were decreased in CSB-deficient cells
(Figure 3B), and overexpression of exogenous UCP2 signifi-
cantly decreased FCCP-uncoupled respiration, reduced thetabolites in WT and CSB-deficient cells; NMN: Nicotinamide mononucleotide;
various diets. Each lane is a separate mouse.
hr treatments (n = 3–28 separate seahorse experiments, mean ± SEM).
siRNA treatment (n = 3, mean ± SEM).
overexpression (n = 3, mean ± SEM).
and stained with tetramethylrhodamine methyl ester (TMRM) for membrane
EM).
Inc.
Figure 4. b-OHB and PARP Inhibition Rescues the CS Phenotype through SIRT1 Activation
(A) FCCP uncoupled respiration normalized to basal respiration 48 hr after 10 mM b-OHB treatment (n = 3 separate seahorse experiments, mean ± SEM).
(B) Representative immunoblot of treatment of WT and CSB-deficient cells with increasing concentrations of b-OHB.
(C) Flow cytometry of WT and CSB-deficient cells treated with b-OHB and or EX-527 for 48 hr and stained with mitosox (n = 6, mean ± SEM).
(D) Oxygen consumption rate (OCR) relative to ECAR (n = 3–12 separate seahorse experiments, mean ± SEM).
(E) Acetyl-CoA levels after treatment with the PARP inhibitor PJ34 or b-OHB for 24 hr (n = 6, mean ± SEM).
(F) Representative immunoblot of acid-extracted histones after treatment with the PARP inhibitor PJ34 or b-OHB for 24 hr.
(G) Representative immunoblot fromWTandCSB-deficient cells after 24 hr treatmentwithMB-3, NU9056, or increasing concentration of L002 and flow cytometry
of WT and CSB-deficient cells treated with MB-3, NU9056, or increasing concentration of L002 for 24 hr and stained with mitosox (n = 3–12, mean ± SEM).
(legend continued on next page)
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A High-Fat Diet for Cockaynes Syndromemembrane potential, and rescued the mitochondrial ROS pro-
duction in CSB-deficient cells (Figures 3H–3I and S5B for protein
levels). In addition, knockdown of UCP2 increased the mem-
brane potential and mitochondrial ROS production in both CSB
and WT cells (Figure 3I). Taken together, our data indicate that
oxidative stress may lead to PARP1 activation, SIRT1 attenua-
tion, and the mitochondrial phenotype, possibly through loss of
UCP2 expression.
Ketone Bodies and PARP Inhibition Rescue the
Phenotype of CS through SIRT1 Activation
Since the HFD appeared to increase the levels of ketone bodies,
we further investigated the effect of these metabolites in CS.
Notably, treatment with b-OHB led to a decrease in FCCP-un-
coupled respiration, SIRT1 activation, and increased UCP2
expression in CSB-deficient cells (Figures 4A and 4B). In addi-
tion, b-OHB attenuated ROS production and the mitochondrial
membrane potential, and this effect appeared to depend upon
SIRT1, since its inhibition with EX-527 abolished this effect (Fig-
ures 4C and S6A). Interestingly, PARP inhibition using either
PJ34 or NU1025 also increased SIRT1 levels, perhaps indicating
common pathways between ketone- and PARP-mediated SIRT1
regulation (Figure S6B). Considering b-OHB treatment could in-
crease the intracellular pool of acetyl-CoA, we speculated that
PARP inhibition could do the same by changing the lactate/pyru-
vate equilibrium, thereby increasing the conversion of pyruvate
to acetyl-CoA. This appeared to be the case since PARP inhibi-
tion increased the OCR/ECAR ratio (Figure 4D). Further, PARP
inhibition and b-OHB treatment normalized the acetyl-CoA levels
in CSB-deficient cells (Figure 4E). In addition, decreasing flow
through glycolysis by incubating the cells in 5 mM glucose led
to an increase in FCCP-uncoupled respiration in WT cells, while
there was no change in the CSB-deficient cells (Figure S5A).
Conversely, incubating cells in oleic acid, which will increase
acetyl-CoA levels, normalized the FCCP-uncoupled respiration
in CSB-deficient cells (Figure S5A).
Since SIRT1 is a histone deacetylase and acetyl-CoA levels
regulate histone acetylation levels, we speculated that there
might exist a feedback loop regulating the levels of SIRT1 in
response to general histone acetylation levels. Accordingly,
b-OHB treatment and PARP inhibition led to increased histone
acetylation at sites known to be acetylated after ketone body
exposure (Figure 4F) (Shimazu et al., 2013). Histone acetylation
is mediated through histone acetyl transferases (HATs). A num-
ber of pharmacological HAT inhibitors have been developed:
L002, is an inhibitor of p300, CBP, GCN5, and PCAF; NU-
9056 inhibits Tip60; MB-3 inhibits GCN5; C646 inhibits P300.
Interestingly, WT cells were sensitive (in terms of cell growth)
to inhibition by L002, while CS cells were comparatively
resistant, indicating that the CSB-deficient cells may have
adapted to chronically low activity of HATs inhibited by L002
(Figure S6C). Indeed, L002 treatment led to loss of SIRT1
expression and a similar mitochondrial phenotype in WT cells
compared with CSB cells (Figures 4G and S6D). Importantly, in-(H) Representative immunoblot of protein levels after knockdown of various prot
(I) Flow cytometry of WT and CSB-deficient cells subjected to siRNA knockdown
(J) Representative immunoblot of protein levels after treatment with L002 and/or
(K) Representative immunoblot of protein levels after treatment with L002 and/or
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to changes in mitochondrial function (Figures 4G, S6D, and
S6E). There was also no effect on mitochondrial parameters
by inhibiting P300 using C646 (Figure S6F). To further under-
stand which HAT may be responsible for alterations in SIRT1
protein levels, we performed knockdown of p300, CBP,
GCN5, and PCAF. Notably, knockdown of PCAF, a known inter-
action partner SIRT1 in the DNA damage response (Pediconi
et al., 2009), led to significant loss of SIRT1 protein in WT cells
and a strong CS-like mitochondrial phenotype (Figures 4H, 4I,
and S6G). Further, the increase in SIRT1 protein levels upon
b-OHB appeared to depend on HAT activity, since cotreatment
with b-OHB and L002 failed to rescue SIRT1 levels in CSB-defi-
cient cells (Figure 4J). To understand whether the regulation of
SIRT1 protein levels happened at the transcriptional level, we
measured the activity of the SIRT1 promoter using a luciferase
assay and found that at higher concentration L002 treatment
appeared to stimulate SIRT1 transcription (Figure S6H). We
therefore investigated if the SIRT1 protein stability might be
altered by L002 by coincubation with the proteasomal inhibitor
MG-132. Indeed, MG-132 treatment rescued the SIRT1 protein
levels in CSB-deficient cells as well as in L002-treated WT cells
(Figure 4K). In summary, it appears that loss of SIRT1 expres-
sion and activity may in part be due to loss of acetyl-CoA levels
caused by shunting of glucose to lactate, possibly leading to
less PCAF-dependent acetylation activity.
Ketones and PARP Inhibition Are Nonadditive in their
Ability to Extend the Lifespan of CSB Nematodes
It has recently been shown that age-associated PARP activation
is conserved from nematodes to mammals (Mouchiroud et al.,
2013). We therefore investigated this phenomenon in csb-1
(worm CSB ortholog) mutant worms (csb-1). Indeed, PAR levels
were significantly increased in the aged csb-1 worms compared
to WT (N2) and young nematodes (Figure 5A). Concomitantly,
we observed a decrease in Sir2 (worm SIRT1 ortholog) levels
(Figure 5A). Since ketones bodies may be able to reverse
some of the phenotypes in human and mouse CS, we asked if
b-OHB, PARP, or a combination of these interventions would
extend the lifespan in worms. Csb-1 worms displayed short-
ened lifespan as compared with N2 (mean lifespan 17.3 days
in Csb-1 versus 19.1 days in N2) and b-OHB treatment, PARP
inhibition using PJ34, or a combination of the two, completely
rescued this defect in lifespan (Figures 5C–5E). Since the com-
bination treatment did not increase lifespan further than each of
the single interventions, the data support the idea that PARP in-
hibition and ketone bodies may increase lifespan through the
same pathway by augmenting acetyl-CoA levels and increasing
SIRT1 expression (Figure 5F). In WT N2 worms, neither PJ34 nor
b-OHB led to lifespan extension (Figures 5G and 5H); however,
the combined treatment did lead to a slight but significant in-
crease in N2 lifespan (Figure 5I). Nonetheless, there was no sig-
nificant difference when comparing each of the interventions,
indicating that the same pathway may be activated by theseeins.
of various proteins and stained with mitosox (n = 3, mean ± SEM).
b-OHB.
MG-132.
Inc.
Figure 5. The Longevity Effect of b-OHB and PARP Inhibition Are Nonadditive in Short-Lived csb-1 Nematodes
(A) Representative immunoblot from old and young csb-1 and N2 worms. Each lane represents a separate worm cohort.
(B) Kaplan-Meier survival curves of csb-1 and N2 nematodes (n = 100).
(C) Survival curves of csb-1 nematodes treated with 0.1 mM PJ34 (n = 50).
(D) Survival curves of csb-1 nematodes treated with 25 mM b-OHB (n = 50).
(E) Survival curves of csb-1 nematodes treated with 0.1 mM PJ34 and 25 mM b-OHB (n = 50).
(F) Survival curves of csb-1 nematodes treated with 0.1 mM PJ34, 25 mM b-OHB, or 0.1 mM PJ34 and 25 mM b-OHB (n = 50).
(G) Survival curves of WT N2 nematodes treated with 0.1 mM PJ34 (n = 50).
(legend continued on next page)
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and N2 worms on the combination treatment was identical
(Figure 5K).
CSB Is Retained at DNA Damage Sites by PAR to
Displace PARP1 from DNA
Considering that PARP1 inhibition appeared to attenuate the
CS phenotype and that CSB is known to interact with
PARP1 (Thorslund et al., 2005), we investigated the functional
relationship between these proteins in greater detail. CSB has
previously been shown to displace proteins from DNA (Ber-
quist and Wilson, 2009), and we therefore speculated that
CSB may interact with and/or modulate PARP1 on DNA.
Consistent with this notion, a different binding pattern was
observed in an electrophoretic mobility shift assay of the
PARP1-DNA complexes when incubated with CSB (Figure 6A).
To further characterize this phenomenon, we examined the
ability of CSB to displace PARP1 from a BamH1 restriction-
site-containing DNA duplex. Interestingly, CSB was only able
to displace PARylated PARP1 and not unmodified PARP1
(shown by increased BamH1 cleavage of the DNA), indicating
that PARP1 has to be activated before it can be removed
from DNA (Figure 6B). In support of this idea, recombinant
CSB decreased the DNA-dependent ribosylation activity of
PARP1 in the presence of UV-damaged DNA in vitro (Fig-
ure 6C). It was recently shown that UV radiation can activate
PARP1 (Robu et al., 2013). To test if CSB would modulate
the activity of PARP in vivo, we irradiated cells with 5 J/m2
and measured the activation of PARP over time. Indeed, UV
damage led to a modest activation of PARP in the WT cells
over time. In CSB-deficient cells, PARP was strongly acti-
vated, and the activation persisted, supporting the idea that
CSB participates in the removal of PARP on damaged DNA
(Figure 6D).
Since PARylation status apparently modulated the activity of
CSB, we measured the recruitment of CSB to laser-induced
DNA damage after PARP inhibition. We observed that CSB
recruitment was independent of PARP activation, whereas
retention of CSB at the site of damage was influenced by PAR
polymers (Figure 6E). Indeed, CSB appeared to have an extraor-
dinary strong ability to bind PAR noncovalently in vitro, as
demonstrated by far-western and slot blot assays. Here, far-
western showed increasing PAR binding with increasing CSB
loaded (Figure S6I). We confirmed the results using slot blot
showing dose-dependent PAR binding to CSB (Figure 6F; his-
tone H1 is a positive control; BSA is a negative control). In sup-
port of this, two conserved PAR binding motifs (Pleschke et al.,
2000) were identified in the N-terminal PARP1 binding region
of CSB, and mutating the lysines to alanines in these sites led
to loss of retention of CSB at the damage (Figures 6G and 6H).
Further, CSB retention in PARP1 null HeLa cells was also
decreased, supporting the role of PAR binding in the retention
of CSB at the damage (Figure 6I). Thus, CSB may be retained(H) Survival curves of WT N2 nematodes treated with 25 mM b-OHB (n = 50).
(I) Survival curves of WT N2 nematodes treated with 0.1 mM PJ34 and 25 mM b-
(J) Survival curves of WT N2 nematodes treated with 0.1 mM PJ34, 25 mM b-OH
(K) Survival curves of WT N2 and csb-1 nematodes treated 0.1 mM PJ34 and 25
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and facilitate the removal of PARylated PARP1 from the DNA
to enable downstream DNA repair to occur.
PARP Inhibition or NAD+ Replenishment Rescues the
Mitochondrial Phenotype in CS
Since PARP activation appeared to drive much of the phenotype
in CS, we asked whether inhibition of this enzyme could rescue
the mitochondrial dysfunction. Accordingly, treatment with
3AB, NU1025, and PJ34 led to a significant decrease in oxygen
consumption in CSB-deficient cells compared with WT cells,
perhaps indicating that PARP activation drives increased ATP
consumption in CSB-deficient cells (Figure 7A). Further, 24 hr
treatments with these inhibitors decreased the mitochondrial
ROS production in CSB-deficient cells (Figure 7B). PJ34 has
shown anti-inflammatory and neuroprotective properties in vivo
(Hamby et al., 2007). We therefore investigated the effect of this
compound on the metabolism of Csbm/m mice by daily intraper-
itoneal injections while housing the mice in metabolic cages. As
expected, PJ34 treatment decreased oxygen consumption rates
over time in old Csbm/m and to some extent in old WT mice,
whereas young mice of either genotype showed no effect of
this compound (Figure 7C). These data suggest that an age-
related increase in DNA damage may drive the hypermetabolic
phenotype in CS.
Supplementation with NAD+ precursors have recently been
shown to recover defects caused by age-associated increases
in PARP activation (Gomes et al., 2013; Mouchiroud et al.,
2013). We therefore treated old and young Csbm/m mice with
nicotinamide riboside (NR). As expected, old Csbm/m mice had
decreased NAD+ and ATP levels before the treatment. Remark-
ably, a single week of treatment with NR completely normalized
these levels (Figures 7D and 7E). Furthermore, isolated cere-
bellar mitochondria from Csbm/m mice show increased mem-
brane potential as well as ROS production, and NR treatment
rescued these defects (Figures 7F–7I). Because increasing
NAD+ levels should activate transcription factors, we next iso-
lated RNA from the cerebellum of the old and young WT and
Csbm/m mice and performed microarray studies. PCA of the
average Z scores of the entire data set revealed separation of
old and young mice along PC1 (x axis) that accounted for 43%
of the total variability among the data sets (Figure 7J). Notably,
saline-treated Csbm/mmice were furthest to the left on PC1, sup-
porting the idea that this mouse model may indeed represent an
accelerated agingmodel. Importantly, NR treatment resulted in a
normalization of the cerebellar transcriptome in the old Csbm/m
mice (Figure 7K). This was supported by examining individual
gene expression data where 370 genes were significantly
changed when comparing saline-treated old Csbm/m mice
versus to WT mice, and only 173 genes were significantly
changed when comparing NR-treated old Csbm/m mice to old
WT mice (Figure 7K). The same was observed when looking at
significantly changed gene ontology terms, where saline-treatedOHB (n = 50).
B, or 0.1 mM PJ34 and 25 mM b-OHB (n = 50).
mM b-OHB (n = 50).
Inc.
Figure 6. CSB Inhibits PARP1 Activation In Vitro and In Vivo through Displacement of PARylated PARP1 from DNA
(A) Electromobility shift assay (EMSA) of PARP1 and CSB binding to double-stranded DNA.
(B) BamH1 incision of a 42-mer oligo preincubated with 250 nM PARP1 and with increasing amounts of CSB with or without NAD+ (n = 3, mean ± SEM).
(C) Representative immunoblot and quantification of in vitro poly-ADP-ribosylation (PARylation) of CSB and PARP1. Reactions were performed with recombinant
proteins in the presence of undamaged or damaged DNA (n = 3, mean ± SEM).
(legend continued on next page)
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terms, while NR-treated Csbm/m mice versus WT only had 110
changed pathways (Figure 7L). Interestingly, looking closer at
the GO terms that were corrected by NR treatment revealed
complete normalization of the mitochondrial pathways, as well
as normalization of terms involved in oxidative stress, transcrip-
tion, DNA repair, DNAdamage response, and histone acetylation
(Tabel S1). In summary, PARP inhibition or NAD+ replenishment
appears to rescue the CS-associated phenotypes in human cells
and mice, supporting the role of PARP activation in the patho-
genesis of this disorder.
DISCUSSION
We found that a HFD rescues neurological and metabolic phe-
notypes of a mouse model of the accelerated aging disorder
CS. CSB deficiency leads to PARP1 activation, NAD+ deple-
tion, and attenuation of SIRT1. The HFD did not alter glucose
homeostasis but moderately increased the levels of the circu-
lating ketone b-OHB. PARP1 inhibitors or b-OHB treatment
also rescue lifespan defects in csb-1 nematodes and mitochon-
drial defects in CSB-deficient human cells. This may occur
through acetyl-CoA-mediated activation of PCAF leading to
increased expression of SIRT1. CSB is able to remove PARy-
lated PARP1 from DNA and inhibit its polymerization activity
in the presence of damaged DNA. CSB is recruited to sites of
DNA damage through transcription (Menoni et al., 2012) but
may be retained at the lesion by binding to the PAR-polymer.
We propose that once at the site of DNA damage, CSB is re-
tained by PAR and subsequently removes PARylated PARP1
to allow downstream repair to occur. In total, loss of CSB
may lead to mitochondrial dysfunction and a proinflammatory
and proapoptotic state by hyperactivation of PARP1 and
SIRT1 attenuation.
Several theories regarding the pathogenesis of CS have
evolved. These include roles for CSB in basal transcription, as
well as two central DNA repair pathways, namely, transcrip-
tion-coupled nucleotide excision repair and base excision repair
(Scheibye-Knudsen et al., 2013a). Transcription-coupled nucle-
otide excision repair is a versatile pathway that deals with a large
number of lesions that are able to stall RNA polymerases. It has
been proposed that CSB and CSA participate in the ubiquitina-
tion of a stalled RNA polymerase (Hanawalt and Spivak, 2008).
This may facilitate either the removal or backtracking of the po-
lymerase from the DNA lesion to allow downstream repair pro-
cesses to occur. In addition, CSB has been implicated in base
excision repair, the pathway that deals with single-base lesions
often caused by oxidative stress (Scheibye-Knudsen et al.,
2013a). Notably, PARP1 plays a major role in this pathway. We
nowpropose that CSB recruitment to DNAdamage is dependent
on transcription, while retention depends on PARP activation.
Our study thereby suggests that there may be a crosstalk be-(D) Representative immunoblot of whole cell (PARylation) after 5 J/m2 treatment
(E) Recruitment of GFP-tagged CSB to laser-induced DNA damage after 1 hr pre
(F) Representative slot-blot showing noncovalent interaction between CSB and P
(G) The PAR binding motif in CSB.
(H) Recruitment to laser-induced DNA damage of GFP-tagged WT CSB or CSB
(I) Recruitment of GFP-tagged WT CSB to laser-induced DNA damage in WT He
852 Cell Metabolism 20, 840–855, November 4, 2014 ª2014 Elseviertween base excision repair and transcription that could be cen-
tral in the pathogenesis of CS.
Csbm/m mice represents a reasonable model for mild human
CS and thus potentially for neuronal aging. Like the Csbm/m
mouse, human CS patients have increased lactate production,
which may be a result of increased PARP activation, loss of
NAD+, alterations in the lactate/pyruvate ratio, and decreased
levels of acetyl-CoA. The pleiotropic effects on the metabolism
of alterations in NAD+ could be profound. For example, fatty
acid synthesis is dependent on acetyl-CoA, and the loss of fat
mass, as is reported in CS patients and Csbm/m mice, could be
a result of decreased shunting of glucose to acetyl-CoA. Simi-
larly, leukodystrophy is prevalent in CS patients, and loss of
acetyl-CoA could lead to defects in myelin synthesis. Further,
recycling of NAD+ is energetically expensive with a cost of 4
ATP-equivalents for each NAD+ molecule metabolized. Our
data suggest that PARP may be a factor driving the relative
increased energy consumption seen with age in Csbm/m mice.
The increased energy consumption could account for the main-
tained glucose homeostasis in the HFD-treated Csbm/m mice. In
addition, a shift in the lactate/pyruvate ratio could lead to
decreased glucose utilization in the mitochondria where the
HFD could supply acetyl-CoA necessary for oxidative phosphor-
ylation. Although speculative, this could lead to the decrease in
RER observed in the HFD-treated Csbm/m mice.
Mitochondrial maintenance may be central in the aging pro-
cess, and interventions that preserve mitochondrial function
appear to extend the lifespan of model organisms. Ketones
are known to increase mitochondrial biogenesis and the
expression of UCPs (Bough et al., 2006; Sullivan et al., 2004).
Importantly, SIRT1 is known to regulate both these factors
through activation of downstream transcription factors such
as PGC-1a (Houtkooper et al., 2012). In fact, the PGC-1 family
of transcription factors was first discovered as regulators of
UCP expression (Puigserver et al., 1998). Here, we show that
SIRT1 and UCP2 expression is activated by ketones in CSB-
deficient cells, perhaps explaining some of the effect of the
ketogenic diet on mitochondrial health. Further, it appears
that PARP inhibition and ketone body treatment are nonaddi-
tive in their ability to extend the lifespan of Csb-1 worms, indi-
cating that they work in the same pathway. Although somewhat
speculative, the transcriptomic data on the diet-treated mice
support this hypothesis, since mice treated with resveratrol or
the HFD show similar gene expression profiles in the cere-
bellum. We should, however, note that the HFD could affect
the cerebellum in other ways than merely through increased
ketone levels. Nevertheless, our combined results imply that
these interventions converge on the same central transcription
factor: SIRT1.
Ketone bodies as well as triglycerides are hydrolyzed to yield
acetyl-CoA molecules. Increasing acetyl-CoA levels alter the
epigenetic landscape through stimulation of histone acetylationin WT and CSB-deficient cells at various time points.
incubation with PARP inhibitors 3AB or PJ34.
AR.
harboring K to A mutations in the four conserved lysines.
La or PARP1/ HeLa cells.
Inc.
Figure 7. PARP Inhibition or NAD+ Replenishment Rescues CS-Associated Alterations in Mice and Human Cells
(A) Measurements of the oxygen consumption rate using the Seahorse XF24 analyzer while adding increasing doses of the PARP inhibitors 3AB, NU1025, or PJ34
(n = 3 separate experiments, mean ± SEM).
(legend continued on next page)
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where acetyl-CoA levels are low as in CS. Histone acetylation
can act as a positive regulator of transcription, and this is partic-
ularly relevant for CS. A hallmark feature of CS cells is the inability
to resume RNA synthesis after UV-irradiation as well as an over-
all decreased level of transcription (Mayne and Lehmann, 1982).
These observations led to the idea that CSA and CSB may be
transcription factors that are part of the general transcriptional
machinery (Laine´ and Egly, 2006). The current evidence implies
that DNA damage leads to decreases in NAD+ levels, the
lactate-pyruvate ratio, and total acetyl-CoA levels, which in
turn leads to decreased overall histone acetylation and conse-
quently inhibition of transcription. Since PARP is persistently
activated upon DNA damage in CS, this could perhaps explain
the failure to resume RNA synthesis after UV irradiation.
In closing, our findings provide evidence of a nuclear-mito-
chondrial crosstalk in CS that centers on persistent activation
of a DNA damage response through PARP1 and a concomitant
decrease in NAD+ and acetyl-CoA levels. Accordingly, interven-
tions that increase the NAD+ or acetyl-CoA rescue CS-related
phenotypes, thereby representing novel treatments for this
incurable accelerated aging syndrome.
EXPERIMENTAL PROCEDURES
Animals
Four-month-old mice were fed a standard AIN-93G diet (SD; carbohy-
drate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum or at 40% CR, a
SD-supplemented with 100 mg/kgchow resveratrol ad libitum, or a HFD ad
libitum consisting of AIN-93G with 60% of calories from fat, primarily hydroge-
nated coconut oil (HFD; carbohydrate:protein:fat ratio of 16:23:61). WT and
Csbm/m are on a C57Bl6 background. All measurements were done at 1 year
of age. Unless otherwise stated, blood samples were collected after 6 hr of
fasting at approximately 6 hr into the light cycle. Body weight and food intake
were monitored every other week. Animal rooms were maintained at 20C
and a 12 hr light/dark cycle. All animal protocols were approved by the
Animal Care and Use Committee (352-LEG-2012) of the National Institute on
Aging.
Metabolic Assessment
Metabolic rate of the mice was assessed by indirect calorimetry in open-cir-
cuit oxymax chambers using the Comprehensive Lab Animal Monitoring
System (CLAMS; Columbus Instruments, Columbus). For PJ34 injection ex-
periments mice were acclimatized to monitoring cages for 3 days where
daily saline injections were given. Body composition was measured using
nuclear magnetic resonance spectroscopy before and after starting the
experiment.
Cell Culture
SV40-transformed CS1AN cells stably transfected with either CSB (WT
CSB) or empty vector were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% FBS, 1% pen-strep, and 400 mg/ml genet-(B) Flow cytometry of mitochondrial superoxide production in WT and CSB-defic
(C) Whole-body oxygen consumption rates in 4-month-old (young) and 16-mon
(25 mg/kg body weight) (n = 3–8, right is the quantification of the slopes).
(D and E) NAD+ and ATP levels in the cerebellum of young and oldWT andCsbm/mm
(F–I) Membrane potential and ROS production in isolated mitochondria from the
(J) A PCA and hierarchical clustering of transcriptomic changes in the cerebellum
(K) Venn diagram of significantly changed gene expressions when comparing old
NR-treated mice versus old WT saline.
(L) Venn diagram of significantly changed gene expressions when comparing old
NR-treated mice versus old WT saline.
854 Cell Metabolism 20, 840–855, November 4, 2014 ª2014 Elseviericin and grown in 20% O2/5% CO2 at 37C. PARP1 knockout HeLa cells
were a kind gift of A. Mangerich, A. Bu¨rkle, and E. Ferrando-May. Treat-
ments done: resveratrol 100 mM for 48 hr; Srt1720 3 mM for 48 hr;
NU1025 100 mM for 48 hr; PJ34 10 mM for 48 hr; 3AB 1 mM for 48 hr;
b-OH-butyrate 10 mM for 48 hr; A-769662 10 mM for 48 hr; AICAR 1 mM
for 48 hr; Dorsomorphin 5 mM for 48 hr; 3%O2 treatment 72 hr; LW6 2.5/
5 mM for 48 hr; siRNAs for 72 hr; 0.5 mM Oleic acid for 72 hr; 5 mM glucose
for 72 hr; 100 mM EX-527 for 24 hr; 5/10/20 mM L002 for 24 hr; 50 mM MB-3
for 24 hr; 10 mM NU9056 for 24 hr; 5 mM C646 for 24 hr; 10 mM MG-132 for
5 hr.
Oxygen Consumption
Oxygen consumption and ECAR measurements were performed using the
Seahorse XF-24 instrument (Seahorse Biosciences, North Billerica). Oxygen
consumption in isolated mitochondria was done in the Oroboros oxygraph
(Oroboros, Innsbruck, Austria).
NAD, Ketones, and Acetyl-CoA Measurements
Performed using either commercially available kits or through liquid chroma-
tography-tandem mass spectrometry.
Nematode Studies
Bristol N2 (WT) and csb-1 worms (ok2335) were outcrossed five times to the
N2 prior to use. Lifespan analysis was performed at 25C on classical NGM
plates, or NGM plates supplemented with 25 mM b-OHB seeded with E. coli
OP50 as food source. 25 L4 stage worms (Day 0) were transferred to two
plates, to give synchronous populations of 50 animals per condition. Animals
were scored as dead or alive and transferred every day to fresh plates during
the fertile period.
Flow Cytometry
Cells were washed in PBS once and trypsinized. Cells were then resuspended
in DMEM without phenol red supplemented with 10% FBS containing 50 nM
mitotracker Green FM (Invitrogen, Carlsbad), 20 nM TMRM (Invitrogen, Carls-
bad), 3 mMdihydroethidium (Invitrogen, Carlsbad), or 3 mMmitosox (Invitrogen,
Carlsbad).
See Supplemental Experimental Procedures for detailed methodologies.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2014.10.005.
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